Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Saroj Kunnakkat"'
Autor:
Saroj Kunnakkat, Adaobi Ijeoma Bisi‐Onyemaechi, Alex Chen, Eric Curfman, James Dolbow, Ameena Shafiq, Neel Fotedar
Publikováno v:
Epileptic Disorders.
Autor:
Srinath Ramaswamy, Nadege Gilles, Angelika Gruessner, Dee Burton, Marilyn Fraser, Sarah Weingast, Saroj Kunnakkat, Aimee Afable, David Kaufman, Jonathan Singer, Clotilde Balucani, Steven R Levine
Publikováno v:
Stroke. 54
Introduction: Existing mobile health (mHealth) smartphone applications (apps) for stroke survivors (SS) are poorly adopted. Little is known about SS’ perceptions and preferences for such apps. We conducted a national survey of SS' preferences for a
Autor:
Jinu Thomas, Saroj Kunnakkat, Sarah Weingast, Steven R. Levine, Dee Burton, Clotilde Balucani, Nadege Gilles, Pirouz Piran, Abhishek Pandey
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 28:104318
Recent studies estimate nearly half of the US population can access mobile medical applications (apps) on their smartphones. The are no systematic data available on apps focused on stroke survivors/caregivers.To identify apps (a) designed for stroke
Autor:
Shirley Girouard, Steven R. Levine, Nadege Gilles, Dee Burton, Sarah Weingast, Amy Jensen, Mohammad Faysel, Jonathan B. Singer, Saroj Kunnakkat, Dimitre G. Stefanov, Marilyn Fraser-White
Publikováno v:
Stroke. 48
Background: Nurses play a critical role supporting informal caregivers of stroke patients and thus need evidence of best, client centered interventions. Although there is a growing literature evaluating interventions, there is a paucity of research t
Publikováno v:
Cancer Chemotherapy and Pharmacology. 70:353-363
Central to the process of brain tumor development is angiogenesis, which involves a host of molecules and receptors. In recent years, antiangiogenic therapies have been developed and tested for their effectiveness against these tumors. Among them are
Autor:
Shahzad Raza, Deborah Gruber, Patricia Eagan, Saroj Kunnakkat, Ashwatha Narayana, David Zagzag, Michael L. Gruber, John G. Golfinos, Erik C. Parker
Publikováno v:
Journal of Neurosurgery. 116:341-345
Object The presence of angiogenesis is a hallmark of glioblastoma (GBM). Vascular endothelial growth factor (VEGF), which drives angiogenesis, provides an additional target for conventional therapy. The authors conducted a prospective clinical trial
Autor:
Saroj Kunnakkat, Ashwatha Narayana, Moses Tam, John G. Golfinos, Erik C. Parker, Yelena Novik, Shahzad Raza
Publikováno v:
Medical Oncology. 31
HER2-positive breast cancer is a known risk factor for CNS metastases, and the use of trastuzumab in the adjuvant setting does not prevent brain metastases. The purpose of this study is to compare outcomes in HER2-positive and HER2-negative intracran
Autor:
Eileen P. Connolly, John G. Golfinos, Erik C. Parker, Michael L. Gruber, Saroj Kunnakkat, Josephine Vera King, Ashwatha Narayana, Moses Tam, Maya Mathew
Background. Whole brain radiation therapy (WBRT) reduces local recurrence in patients after surgical resection of brain metastases without improving overall survival. Involved field radiation therapy (IFRT) has been used at our center to avoid delaye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6debcc90c7191b9f5e2fa278cf4030f5
https://europepmc.org/articles/PMC3635512/
https://europepmc.org/articles/PMC3635512/
Autor:
Saroj Kunnakkat, Ashwatha Narayana
Publikováno v:
Angiogenesis. 14(4)
Angiogenesis is a process that is integral to the pathogenesis of high-grade gliomas. Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor has emerged as an important therapeutic agent. Data from clinical trials in
Autor:
Saroj Kunnakkat, Ashwatha Narayana, Deborah Gruber, Praveen Medabalmi, David Zagzag, John G. Golfinos, Erik C. Parker, Edmond A. Knopp, Michael L. Gruber, Patricia Eagan
Publikováno v:
International journal of radiation oncology, biology, physics. 82(1)
Local recurrence is the dominant pattern of relapse in high-grade glioma (HGG) after conventional therapy. The recent use of antiangiogenic therapy has shown impressive radiologic and clinical responses in adult HGG. The preclinical data suggesting i